Rifampicin Treatment of Cutaneous Leishmaniasis

Zvi Even‐Paz, Louis Weinrauch*, Rita Livshin, Joseph El‐On, Charles Leonard Greenblatt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

ABSTRACT: In a small‐scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.

Original languageEnglish
Pages (from-to)110-112
Number of pages3
JournalInternational Journal of Dermatology
Volume21
Issue number2
DOIs
StatePublished - Mar 1982
Externally publishedYes

Fingerprint

Dive into the research topics of 'Rifampicin Treatment of Cutaneous Leishmaniasis'. Together they form a unique fingerprint.

Cite this